W. R. Berkley
WRBNYSEUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $76.83 Prior regular-session close from the quote source.
- $75.33–$76.71 Regular-session low and high so far today.
- 1.4M Regular-session shares traded · Nov 11, 4:00 PM ET.
- Jan 25 projected Projected for 2027-01-25 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $62.87–$79.26 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own WRB if W. R. Berkley generates durable value by underwriting diversified specialty commercial risks globally with disciplined pricing and capital-conservative balance-sheet management, converting underwriting and investment income into consistent earnings, cash flow and capital return.
WRB price history
Loading recent earnings…
Investment thesis
What must happen next
Berkley’s underwriting discipline and product/geographic diversification will keep underwriting losses and reserve volatility contained, allowing net income and operating cash flow to remain resilient through cycles.StrengtheningMateriality: High
net_income rose from $1,022,490,000 in FY2021 to $1,779,403,000 in FY2025 (reported net_income values). If underwriting discipline holds, earnings and cash flow remain predictable and support capital returns; if it fails, the company must rebuild capital, curtail underwriting or dilute shareholders.
Watch: Material adverse reserve development on prior accident years (large additions to loss reserves disclosed in reserve schedules) would demonstrate failed underwriting assumptions.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
net_income rose from $1,022,490,000 in FY2021 to $1,779,403,000 in FY2025 (reported net_income values).
Open source ↗Berkley’s diversified specialty portfolio and international footprint will enable revenue (premiums written) to continue growing organically and by targeted acquisitions without concentrated exposure to any single cycle.StrengtheningMateriality: High
Revenue increased from $9,455,466,000 in FY2021 to $14,707,856,000 in FY2025 (revenue values show multi-year growth). Sustained premium growth expands the earnings base and leverages fixed cost and underwriting infrastructure; loss of diversification or concentrated exposure would make results more volatile.
Watch: Large competitors or reinsurers entering Berkley’s niche specialty segments, compressing margins and making it harder to grow without sacrificing pricing.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Revenue increased from $9,455,466,000 in FY2021 to $14,707,856,000 in FY2025 (revenue values show multi-year growth).
Open source ↗A growing, conservative balance sheet (rising assets and equity with manageable liabilities) provides capital capacity to write more specialty premium and pursue selective M&A without raising equity.StrengtheningMateriality: Medium
Total assets increased from $32,086,414,000 (FY2021) to $43,926,843,000 (FY2025) (assets values indicate balance-sheet growth). If capital capacity holds, Berkley can scale premium and deploy excess capital into accretive deals and buybacks; if capital is constrained by losses or ratings downgrades, growth and returns will be curtailed.
Watch: A rating agency downgrade or large adverse reserve/catastrophe hit that meaningfully reduces available capital or increases regulatory capital needs.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Total assets increased from $32,086,414,000 (FY2021) to $43,926,843,000 (FY2025) (assets values indicate balance-sheet growth).
Open source ↗Berkley will sustain EPS growth and free-cash conversion through combined underwriting and investment income, enabling continuing shareholder distributions.HoldingMateriality: Medium
eps_diluted rose from $3.66 in FY2021 to $4.45 in FY2025 (eps_diluted values show upward trend). Sustained EPS and cash generation justify the valuation and fund buybacks/dividends; a breakdown means lower returns to shareholders and possible multiple compression.
Watch: Sustained underwriting deterioration (high combined ratios) or large unrealized/realized investment losses that compress net income and EPS.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
eps_diluted rose from $3.66 in FY2021 to $4.45 in FY2025 (eps_diluted values show upward trend).
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Berkley’s underwriting discipline and product/geographic diversification will keep underwriting losses and reserve volatility contained, allowing net income and operating cash flow to remain resilient through cycles. If underwriting discipline holds, earnings and cash flow remain predictable and support capital returns; if it fails, the company must rebuild capital, curtail underwriting or dilute shareholders.
Berkley’s diversified specialty portfolio and international footprint will enable revenue (premiums written) to continue growing organically and by targeted acquisitions without concentrated exposure to any single cycle. Sustained premium growth expands the earnings base and leverages fixed cost and underwriting infrastructure; loss of diversification or concentrated exposure would make results more volatile.
A growing, conservative balance sheet (rising assets and equity with manageable liabilities) provides capital capacity to write more specialty premium and pursue selective M&A without raising equity. If capital capacity holds, Berkley can scale premium and deploy excess capital into accretive deals and buybacks; if capital is constrained by losses or ratings downgrades, growth and returns will be curtailed.
Berkley will sustain EPS growth and free-cash conversion through combined underwriting and investment income, enabling continuing shareholder distributions. Sustained EPS and cash generation justify the valuation and fund buybacks/dividends; a breakdown means lower returns to shareholders and possible multiple compression.
All standing thesis claims
Original report summary
W. R. Berkley generates durable value by underwriting diversified specialty commercial risks globally with disciplined pricing and capital-conservative balance-sheet management, converting underwriting and investment income into consistent earnings, cash flow and capital return.
Bull case and bear case
Bull case and bear case for Berkley W R
Where the evidence on Berkley W R stands: Holding on the latest evidence (Oct 13, 2026). Of its 4 thesis points, 3 strengthening and 1 holding.
Bull case: what the evidence supports
Berkley’s underwriting discipline and product/geographic diversification will keep underwriting losses and reserve volatility contained, allowing net income and operating cash flow to remain resilient through cycles.
Berkley’s diversified specialty portfolio and international footprint will enable revenue (premiums written) to continue growing organically and by targeted acquisitions without concentrated exposure to any single cycle.
A growing, conservative balance sheet (rising assets and equity with manageable liabilities) provides capital capacity to write more specialty premium and pursue selective M&A without raising equity.
Berkley will sustain EPS growth and free-cash conversion through combined underwriting and investment income, enabling continuing shareholder distributions.
Bear case: what would count against it
Material adverse reserve development on prior accident years (large additions to loss reserves disclosed in reserve schedules) would demonstrate failed underwriting assumptions.
Large competitors or reinsurers entering Berkley’s niche specialty segments, compressing margins and making it harder to grow without sacrificing pricing.
A rating agency downgrade or large adverse reserve/catastrophe hit that meaningfully reduces available capital or increases regulatory capital needs.
Thesis-Break Engine
What has broken in Berkley W R’s thesis
Each break OptimistFi flagged on Berkley W R, dated — with what has historically followed the same kind of break across the market, not a forecast for Berkley W R.
- Price target fell below the stockcondition set before this filing
Across all companies, this kind of break has happened 1,809 times before. Those stocks trailed comparable companies by a median of 1% over the next six months, and 33% of them trailed it by 10 points or more.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
Berkley W R filed an SEC 8-K on 2026-07-20: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedDirector or principal officer change.
Berkley W R filed an SEC 8-K on 2026-06-26: Director or principal officer change. It is a dated development that tests the current thesis.
- MixedEntered a material definitive agreement.
Berkley W R filed an SEC 8-K on 2026-06-11: Entered a material definitive agreement. It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Material adverse reserve development on prior accident years (large additions to loss reserves disclosed in reserve schedules) would demonstrate failed underwriting assumptions.
- Large competitors or reinsurers entering Berkley’s niche specialty segments, compressing margins and making it harder to grow without sacrificing pricing.
- A rating agency downgrade or large adverse reserve/catastrophe hit that meaningfully reduces available capital or increases regulatory capital needs.
- Sustained underwriting deterioration (high combined ratios) or large unrealized/realized investment losses that compress net income and EPS.
WRB news
Loading headlines…
Financial statements
WRB income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
WRB: quick answers
- When does Berkley W R (WRB) report earnings next?
- Berkley W R's next results are projected for January 25, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on October 19, 2026. Earnings calendar
- What is WRB's short interest?
- As of October 30, 2026, 12.2M WRB shares were sold short, 3.27% of its shares outstanding, up 0.3% from the count before. At the stock's average daily volume that is 4.6 days to cover. FINRA publishes the count twice a month. WRB short interest history
- Have members of Congress traded WRB?
- 35 trades in WRB have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed WRB trade
- Which well-known investors own WRB?
- 2 of the 37 well-known funds tracked here reported WRB shares in their latest 13F filings. By share of the fund's portfolio: Markel Group (Tom Gayner), 0.0%; Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios
WRB in well-known investors’ portfolios
2 of 37 funds reported WRB shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Tom GaynerMarkel Group | 0.03% | $4.1M | No change | Q3 2026 |
| Ray DalioBridgewater Associates | 0.00% | $952K | New | Q2 2026 |
